Head and neck cancer trial tests if less frequent chemo doses reduce harsh side effects
NCT ID NCT02994069
Summary
This study is testing two different schedules for giving the chemotherapy drug cisplatin alongside radiation for head and neck cancer. It aims to see if getting the drug once every three weeks causes fewer severe side effects than getting it weekly, while still being effective at controlling the cancer. The trial will also check if certain markers in the body can predict who is more likely to experience these side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.